![](\"https:\/\/mms.businesswire.com\/media\/20260511178309\/en\/2801294\/5\/IMG_6708_cropped.jpg\")
<\/a><\/a>![](\"https:\/\/mms.businesswire.com\/media\/20260511178309\/en\/2801287\/5\/fulllogo.jpg\")
<\/a><\/a>\nThe partnership was formally launched April 22 at a well-attended reception hosted by Lake Norman Pulmonary & Sleep, where Dr. Sever Surdulescu, MD, FCCP, DABSM, the practice\u2019s quadruple board-certified pulmonologist and sleep medicine specialist, introduced the device to patients and community members. Three representatives from Alesis LLC joined Dr. Surdulescu to demonstrate the technology and answer questions. The event marked the opening of the Lake Norman Sleep Center\u2019s Alesis OSA1 program and the launch of the \u201cNo Mo Hose\u201d movement \u2014 a patient-led call to action for the millions of Americans who have abandoned CPAP and gone without effective OSA treatment.<\/p>
\nTHE SLEEP APNEA CRISIS: A DISEASE UNDERTREATED AT SCALE<\/b><\/p>
\nObstructive sleep apnea affects an estimated 30 million Americans, yet remains dramatically undertreated. Patients with untreated OSA face an average reduction in life expectancy of seven years, along with significantly elevated risk for cardiovascular disease, hypertension, type 2 diabetes, stroke, and cognitive decline. Despite these stakes, compliance with CPAP \u2014 the current gold standard of therapy \u2014 is alarmingly low.<\/p>
\nStudies consistently show that 40% to 70% of CPAP patients stop using their devices, citing discomfort from wearing a mask and hose every night, noise, claustrophobia, skin irritation, and difficulty when traveling. These patients have been through the full diagnostic pathway: they received a sleep study, were diagnosed with OSA, had a CPAP prescribed, and even purchased the equipment. Yet they remain untreated and at elevated risk, with no non-surgical alternative \u2014 until now.<\/p>
\nALESIS OSA1\u2122: TREATING THE ROOT CAUSE WITHOUT MASKS OR SURGERY<\/b><\/p>
\nAlesis OSA1 is an FDA-cleared, prescription-only medical device that uses a patented, high-powered non-laser light \u2014 photonic lipolysis \u2014 to permanently reduce the localized fat deposits in the neck, tongue, throat, and airway that are the leading anatomical cause of airway obstruction in most OSA patients. The procedure requires no surgery, no needles, no anesthesia, and no recovery time. Patients receive six 12-minute in-office treatments over three weeks.<\/p>
\nThe device is manufactured in the United States by Photonica USA, LLC, in Cocoa Beach, Florida, and holds three FDA clearances (K160880, K150336, and K202361), along with 11 utility patents granted in 31 countries. The underlying technology has been FDA-cleared for over a decade with no reported side effects or adverse outcomes.<\/p>
\nMulti-site randomized IRB clinical trials NCT06949969 at ClinicalTrials.gov<\/a> demonstrated that 80% of subjects achieved a 51% to 85% improvement in sleep apnea in just three weeks, as measured by Apnea-Hypopnea Index (AHI).<\/p> \nABOUT THE LAKE NORMAN SLEEP CENTER PARTNERSHIP<\/b><\/p> \nLake Norman Pulmonary & Sleep has served the greater Lake Norman and Mooresville community for decades under the leadership of Dr. Sever Surdulescu, MD, FCCP, DABSM. Dr. Surdulescu is quadruple board-certified in internal medicine, pulmonary medicine, critical care, and sleep medicine \u2014 one of a small number of physicians in the region who hold all four designations. His practice specializes in the full spectrum of sleep and pulmonary disorders, and is widely regarded as a regional center of excellence for sleep medicine.<\/p> \nLake Norman Sleep Center is the first sleep medicine practice in the Piedmont region to offer Alesis OSA1, and the first formal joint venture sleep center partnership for Alesis LLC nationwide.<\/p> \n\u201cCPAP is a life-saving technology for many sleep apnea patients, but a significant number of patients do not tolerate wearing a mask and hose every night. For those patients, Alesis OSA1 offers a non-surgical treatment using a special type of non-laser medical light to shrink fat deposits that interfere with sleep.\u201d<\/i><\/p> \n\u201cIn clinical trials, 80% of patients achieved improvement in sleep apnea of more than 50%, with some patients seeing an 85% improvement. We are proud to have been selected to introduce this transformative approach to better breathing and sleep.\u201d<\/i><\/p> \n\u2014 Sever Surdulescu, MD, FCCP, DABSM, Lake Norman Pulmonary & Sleep<\/i><\/p> \n\u201cOur team at Alesis is proud to be partners with Lake Norman Pulmonary and Sleep. Dr. Surdulescu\u2019s team is the best I have ever seen. Working together, we can offer a potentially transformative non-surgical alternative for the thousands of OSA patients in the central Piedmont region.\u201d<\/i><\/p> \n\u201cEvery person\u2019s body responds differently to therapy. Nobody can guarantee an individual\u2019s results; however, we decided as a partnership to offer a money-back guarantee if the treatment does not improve the patient\u2019s sleep apnea by at least 50%.\u201d<\/i><\/p> \n\u2014 Terry J. Ward Sr., MHA, Managing Director and CEO, Alesis LLC<\/i><\/p> \nPATIENT COMMITMENT: RESULTS GUARANTEE AND FLEXIBLE PAYMENT<\/b><\/p> \nAlesis LLC and Lake Norman Pulmonary & Sleep are committed to making this treatment accessible and risk-free for qualifying patients. The program includes:<\/p> \nPatients interested in learning whether Alesis OSA1 may be appropriate for their condition are encouraged to visit AlesisOSA1.com<\/a>.<\/p> \nTHE \u201cNO MO HOSE\u201d MOVEMENT<\/b><\/p> \nLaunched April 22 at the Lake Norman Sleep Center reception, \u201cNo Mo Hose\u201d is a growing patient movement recognizing that millions of Americans have been diagnosed with sleep apnea, prescribed CPAP, and still go untreated every night because they cannot tolerate the mask and hose. It all began when Alesis Managing Director Terry Ward told the crowd, \u201cAnd best of all \u2014 no mask or hose... .\u201d<\/p> \nAttendees began spontaneously chanting, \u201cNo Mo Hose\u201d \u2014 and the movement was born, giving voice to millions of CPAP-intolerant patients and signaling the arrival of a genuine clinical alternative.<\/p> \nABOUT ALESIS LLC<\/b><\/p> \nAlesis LLC is headquartered in Cocoa Beach, Florida, and serves as the exclusive U.S. distributor of the Alesis OSA1\u2122 device. The company is focused on expanding access to non-surgical OSA treatment through partnerships with exemplary sleep medicine practices nationwide. Alesis LLC is led by Terry J. Ward, Sr., M.H.A., who invented photonic lipolysis in 2011 and its application to OSA treatment in 2025. For physician inquiries, contact Terry J. Ward, Sr. directly at 800-248-5051 or visit AlesisMedical.com<\/a>.<\/p> \nABOUT LAKE NORMAN PULMONARY & SLEEP<\/b><\/p> \nLake Norman Pulmonary & Sleep, located in Mooresville, North Carolina, has provided specialized pulmonary and sleep medicine care to the Lake Norman community for decades. The practice is led by Dr. Sever Surdulescu, MD, FCCP, DABSM, who is quadruple board-certified in internal medicine, pulmonary medicine, critical care, and sleep medicine. The practice offers comprehensive diagnostic and therapeutic services for sleep disorders, including the newest non-surgical approaches to OSA treatment.<\/p> \nSafe Harbor \/ Forward-Looking Statements: <\/b>This press release contains forward-looking statements regarding clinical outcomes, patient results, and business expectations. Actual results may vary. Clinical outcomes cited are from IRB-approved trials and individual results may differ. Alesis OSA1 is a prescription-only medical device; patients should consult their physician to determine if treatment is appropriate for their condition.<\/p>\n